Delivery Order SPE2DB24D2012-SPE2DB25FBUUM

Award Date 11/21/24
Potential Completion Date 11/22/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Telmisartan 40 mg tablets in 30-count packages, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $4,277.67 firm fixed-price delivery order contract has an ultimate completion date of October 24, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of telmisartan 40 mg tablets in 30-count packages, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract has a ceiling value of $3,661.09 and a completion date of August 8, 2024. The contract is a Delivery Order under a Firm Fixed Price type, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of 4,563,681,036 units of Telmisartan 40 mg tablets to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract has a ceiling value of $1,433.08 and is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a period of performance through February 16, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug...
The federal contract award detailed is for the delivery of Telmisartan 40 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The prime contractor for this award is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,435.52 with a firm fixed price and a completion date of December 18, 2024. This award is not associated with a set-aside designation, indicating open competition....
This federal contract award is for the delivery of Telmisartan 80 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $1,074.11. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 21, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug...
This federal contract award, valued at $1,323.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Telmisartan 40 mg tablets. The contract has an ultimate completion date of February 19, 2025 and is a firm fixed-price delivery order. The award is not designated as a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Telmisartan 80 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical, a major agency within the U.S. Department of Defense. The fixed-price, $1,207.68 contract was awarded to AmerisourceBergen Drug Corp, a large pharmaceutical distributor, on October 22, 2024. The contract has an ultimate completion date of October 23, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award is for the delivery of Telmisartan 40 mg tablets to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The firm fixed-price delivery order, valued at $1,866.14, has a period of performance through November 2024. It is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive...
This federal contract award is for the delivery of Telmisartan 40 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a ceiling value of $5,653.44 and a performance period through March 22, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan 40 mg tablets. The contract has a firm-fixed price of $1,355.12 and an ultimate completion date of August 21, 2024. AmerisourceBergen has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables...
  • SPE2DB24D2012
    Indefinite Delivery Contract
  • SPE2DB24D2012-SPE2DB25FBUUM
    Delivery Order

This federal contract award is for the delivery of telmisartan 40 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The firm-fixed-price contract is valued at $1,871.31 and has an ultimate completion date of November 22, 2024. It was awarded on November 21, 2024 as a delivery order, without any set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/20/25, 9:22 AM